跳至主要内容
临床试验/NCT00753181
NCT00753181已完成3 期

Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabetes

Abbott Nutrition2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2008年8月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
60
试验地点
2
主要终点
Average daily blood glucose level

研究概览

简要总结

To evaluate average daily blood glucose in subjects with type 2 diabetes following a Meal Plan including Diabetes-Specific products compared to average daily blood glucose in subjects following their usual diet.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •type 2 diabetes
  • •HbA1c >6.5% and <11.0%
  • •male/non-pregnant, non-lactating female, at least 6 months postpartum
  • •if female of childbearing potential, practicing method of birth control
  • •Body Mass Index > 18.5 kg/m2 and < 43.0 kg/m
  • •weight stable for past two months
  • •if on anti-hypertensive, lipid-lowering, thyroid medication or hormone therapy, dosage constant for at least two months

排除标准

  • •uses injected medications (e.g., insulin, exenatide) for glucose control.
  • •history of diabetic ketoacidosis
  • •current infection ; inpatient surgery, or corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks
  • •active malignancy
  • •states he/she has had a significant cardiovascular event < 12 weeks prior to study entry or history of congestive heart failure in the last 12 months.
  • •end stage organ failure
  • •active metabolic, hepatic, or gastrointestinal disease that may interfere with nutrient absorption, distribution, metabolism, or excretion (such as gastroparesis), excluding diabetes.
  • •chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.
  • •use of herbals, dietary supplements, or medications, other than allowed medications, during past four weeks that could profoundly affect blood glucose.
  • •symptomatic in response to blood collection prior to enrollment into this study.
  • •clotting or bleeding disorders.
  • •non-typical eating pattern
  • •is currently using diabetes-specific nutritional product(s)defined as more than one eating occasion per week.
  • •engages in strenuous exercise five or more times per week.

研究组 & 干预措施

A1

Experimental

Diabetes Meal Plan with Experimental Diabetes-Specific nutritional shake

干预措施: Nutritional Formula (Other)

A2

Active Comparator

Usual diet

干预措施: Usual diet (Other)

A3

Experimental

Diabetes Meal Plan with Experimental Diabetes-Specific Nutritional Shake, diabetes specific Cereal, and diabetes specific snack bars.

干预措施: Diabetes Meal Plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, and diabetes specific snack bars. (Other)

结局指标

主要结局

Average daily blood glucose level

时间窗: 11 days

次要结局

  • Percentage of time in specified glucose ranges; Glycemic excursions; Change in plasma glucose, insulin, free fatty acids, triglycerides, 1,5-anhydroglucitol, and fructosamine; Dietary intake variables(11 days)

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验